Get all your news in one place.
100's of premium titles.
One app.
Start reading
Birmingham Post
Birmingham Post
Business
Sion Barry

One of Wales' leading life sciences firms Creo Medical says 2021 revenues will exceed market expectations

One of Wales’ leading life sciences firm, Creo Medical, has seen its share price rally after confirming that revenues for 2021 are expected to be ahead of market expectations at £25m despite the challenges of the pandemic.

The Chepstow-based and acquisitive Alternative Investment Market (AIM) listed business, which focuses on the emerging field of surgical endoscopy, said it was delivering on its ‘build, buy and partner’ strategy.

On the back of the upbeat trading statement, Creo Medical’s share price has risen around 50p to £170p in recent days adding around £91m to its market capitalisation (£311m). However, this time last year its share price was at £2.33p.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.